Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
Status:
Completed
Trial end date:
2020-10-08
Target enrollment:
Participant gender:
Summary
A Multi-Center, Phase 2/3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled,
Clinical Trial to Assess the Safety and Efficacy of Voclosporin Ophthalmic Solution (0.05%,
0.10%, 0.20%) Compared to Vehicle in Subjects with Dry Eye Syndrome.